Table 1 Patient characteristics.

From: Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine

Patient ID

Sex

Age (years)

NYHA class

CCS angina grading scale

LVEF (%)

Cardiac catheterization findings

Medication

#1

M

78

III

IV

65

2 vessel CHD

Acetylsalicylic acid, ramipril, metoprolol, torasemide, pantoprazole, alendronic acid, methylprednisolone, insulin

#2

F

64

III–IV

III–IV

35

2 vessel CHD, AoS

Acetylsalicylic acid, atorvastatin, telmisartan, hydrochlorothiazide, pantoprazole, anastrozole, metformin

#3

M

74

II

III–IV

60

2 vessel CHD, NSTEMI

Metoprolol, apixaban, atorvastatin, torasemide

#4

M

74

III

IV

40

2 vessel CHD

Acetylsalicylic acid, bisoprolol, atorvastatin, ramipril, prasugrel, dapagliflozin, sitagliptin, pantoprazole, torasemide

#5

M

74

II

III–IV

55

3 vessel CHD, STEMI

Acetylsalicylic acid, bisoprolol, atorvastatin, clopidogrel, torasemide, valsartan

#6

M

59

III

III

40

3 vessel CHD, NSTEMI

Acetylsalicylic acid, metoprolol, allopurinol, clopidogrel, pantoprazole, simvastatin, torasemide

#7

M

77

II

III

55

3 vessel CHD, LMCA stenosis

Clopidogrel, apixaban, nebivolol, calcium acetate, doxazosin, moxonidine, pantoprazole, sevelamer carbonate, torasemide, methylprednisolone, xipamide

#8

M

61

III

III

72

3 vessel CHD, LMCA stenosis

Acetylsalicylic acid, bisoprolol, allopurinol, atorvastatin, enalapril, hydrochlorothiazide, omega-3-acid ethyl esters, pantoprazole, budesonide, salbutamol

#9

M

72

III

III–IV

55

2 vessel CHD, NSTEMI

Acetylsalicylic acid, torasemide, pantoprazole, tamsulosin, ezetimibe, candesartan, atorvastatin, amlodipine, apixaban

#10

M

71

II–III

III

50

3 vessel CHD, AoS

Acetylsalicylic acid, metoprolol, amlodipine, atorvastatin, chlorthalidone, moxonidine, pantoprazole, torasemide, valsartan, insulin

#11

M

60

II

III

50

3 vessel CHD, LMCA stenosis

Acetylsalicylic acid, metoprolol, candesartan, dapagliflozin, sitagliptin, rosuvastatin, metformin, clopidogrel, terbinafine

#12

M

59

III

III

30

3 vessel CHD, ICM

Acetylsalicylic acid, metoprolol, atorvastatin, sacubitril/valsartan, ezetimibe, dapagliflozin, metformin, pantoprazole, spironolactone, torasemide

#13

F

75

III

III–IV

40

3 vessel CHD, NSTEMI, ICM

Acetylsalicylic acid, metoprolol, atorvastatin, ezetimibe, ramipril, pantoprazole, prednisolone, torasemide, metamizole

#14

M

71

III

III–IV

55

3 vessel CHD, STEMI, AoS

Acetylsalicylic acid, metoprolol, atorvastatin, candesartan, ezetimibe, pantoprazole, torasemide

#15

M

68

III–IV

III

23

3 vessel CHD, NSTEMI, AoS

Acetylsalicylic acid, metoprolol, amlodipine, atorvastatin, sacubitril/valsartan, eplerenone, glimepiride, dapagliflozin, pantoprazole, metformin, budesonide/formoterol, torasemide, insulin

#16

M

65

III

III

40

3 vessel CHD, LMCA stenosis, STEMI

Acetylsalicylic acid, metoprolol, acetyl cysteine, atorvastatin, levothyroxine, pantoprazole, torasemide, metamizole, insulin

Mean ± SD

 

68.9 ± 6.4

  

47.8 ± 12.7

  
  1. NYHA New York Heart Association, CCS Canadian Cardiovascular Society, LVEF left ventricular ejection fraction, CHD coronary heart disease, AoS aortic stenosis, STEMI ST-segment elevation myocardial infarction, NSTEMI non-ST-segment elevation myocardial infarction, LMCA left main coronary artery, ICM ischemic cardiomyopathy.
Back to article page